| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.42▲ | 1.42▲ | 1.42▲ | 1.39▲ | 2.52▼ |
| MA10 | 1.73▼ | 1.89▼ | 1.92▼ | 1.81▼ | 3.07▼ |
| MA20 | 2.20▼ | 2.44▼ | 2.66▼ | 2.35▼ | 1.82▼ |
| MA50 | 3.40▼ | 4.02▼ | 4.44▼ | 3.23▼ | 1.25▲ |
| MA100 | 4.29▼ | 3.43▼ | 2.87▼ | 1.91▼ | 1.27▲ |
| MA200 | 2.36▼ | 1.97▼ | 1.74▼ | 1.37▲ | 1.25▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.025▼ | -0.053▼ | -0.087▼ | -0.102▼ | -0.049▼ |
| RSI | 22.334▼ | 22.223▼ | 21.564▼ | 29.610▼ | 47.145▼ |
| STOCH | 6.111▼ | 5.307▼ | 4.856▼ | 15.142▼ | 34.183 |
| WILL %R | -87.591▼ | -88.629▼ | -90.761▼ | -79.394▼ | -83.586▼ |
| CCI | -80.056 | -91.756 | -91.003 | -90.313 | -32.789 |
|
Monday, November 02, 2026 06:00 AM
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company developing treatments for neurodegenerative diseases, today announced plans to ...
|
|
Friday, October 02, 2026 01:15 PM
Company regains compliance with Nasdaq's minimum bid price requirement and intends to request a Nasdaq Hearings Panel hearing to seek additional time to regain compliance with the minimum market value ...
|
|
Thursday, September 10, 2026 02:11 PM
Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 1.44 | 1.44 | 1.44 | 1.44 | 6,639 |
| 05/11/26 | 1.50 | 1.59 | 1.34 | 1.395 | 51,320 |
| 04/11/26 | 1.28 | 1.45 | 1.28 | 1.42 | 24,529 |
| 03/11/26 | 1.40 | 1.46 | 1.20 | 1.28 | 25,037 |
| 02/11/26 | 2.02 | 2.04 | 1.10 | 1.43 | 407,490 |
| 30/10/26 | 2.20 | 2.22 | 1.99 | 1.99 | 20,177 |
| 29/10/26 | 2.302 | 2.32 | 2.0902 | 2.13 | 20,577 |
| 28/10/26 | 2.33 | 2.37 | 2.20 | 2.36 | 17,301 |
| 27/10/26 | 2.30 | 2.5999 | 2.28 | 2.37 | 22,274 |
| 26/10/26 | 2.4664 | 2.75 | 2.31 | 2.33 | 29,709 |
|
|
||||
|
|
||||
|
|